Salin Sriudomporn is a Research Associate II/Health Economist in the International Vaccine Access Center (IVAC) at the Johns Hopkins Bloomberg School of Public Health. She has primarily worked on economic impact modeling for the Gavi investment case and WHO’s Immunization Agenda 2030, and has contributed to projects including HIV/AIDS index testing in India, measles school-based campaign delivery in Zambia, and digital health initiatives in Brazil, Ghana, Rwanda, and India. Her current work focuses on costing, financing, funding gaps, and return on investment for immunization programs through the Decade of Vaccine Economics (DoVE) project and Vaccine Economics Research for Sustainability and Equity (VERSE), including the development of the R-Shiny tool for immunization program analysis.
Click the links below to navigate to our IHEA 2025 presentations or our general resource library where you can sort all our resources based on presenter, organizational affiliation, topic, and more.